RxLogix

rxlogix.com · Edison, United States of America

RxLogix is a pharmacovigilance and drug safety software company that provides cloud-based platforms for adverse event case management, signal detection, risk management, and regulatory reporting to pharmaceutical, biotech, and CRO customers. Its products help life sciences organizations comply with global safety regulations, improve safety operations, and analyze safety data across the drug development and post‑marketing lifecycle. The company generates revenue through software licensing, SaaS subscriptions, and related implementation and support services.

Revenue
$10M - $50M
Employees
201 - 1,000
Founded
2011
Headquarters
Edison, United States of America

RxLogix customers on Arbolus

Total customers 25 24 current · 1 former
Reviews growth 8 new reviews since Jun 2026

Customers who reviewed RxLogix

Seniority of RxLogix customers

The largest group of people who reviewed RxLogix holds Director roles (50%), followed by C-Suite (42%) and Manager (8%).

  • Director 50%
  • C-Suite 42%
  • Manager 8%

Customers sample

Product Leader Manager NPS 10 Will renew
Operations Leader Director NPS 9 Will renew
Generalist Manager Director NPS 7 Will renew

Employer names and spend open in the full report, along with the other 22 customers.

What 25 Arbolus experts think of RxLogix

Overall sentiment: Positive

NPS distribution is 32% Promoters, 64% Passives, and 4% Detractors, with an NPS score of 28 and an average NPS of 8.08. 66.7% of respondents indicate intent to renew, while 12.5% would not, and 20.8% are unsure. 60% of customers have used RxLogix for more than one year, and 12% are in pilot. Key feedback themes include strong compliance support, robust analytics, and some concerns about integration and user interface complexity.

Everything 25 customers told us about RxLogix.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

28 Net Promoter Score, from 25 scored reviews
  • Promoters 8
  • Passives 16
  • Detractors 1

Praised

  • Specialization in Pharmacovigilance
  • Compliance and Audit Readiness
  • Integrated Analytics and Visualization
  • AI-Driven Predictive Analytics

Criticised

  • Integration and Interface Complexity
  • Limited Analytics and Customization
  • Vendor Consolidation and Broader Offerings

What RxLogix customers say

Specialization in Pharmacovigilance

“I would definitely recommend this tool because the company is specialized in the safety and PV domain, making it a strong choice for organizations focused on these areas.”

Strategy Leader · Health Care · 10,000+ employees · APAC

Compliance and Audit Readiness

“RxLogix makes regulatory audits much easier by automatically tracking and organizing medication data, which gives us peace of mind and saves significant staff time.”

Operations Leader · Information Technology · 10,000+ employees · APAC

Integrated Analytics and Visualization

“The depth of analytics and integration with visualization tools lets us analyze safety data flexibly, which is a major advantage over other platforms.”

Operations Leader

Renewal intent

Plan to renew 67%
  • Will renew 16
  • Undecided 5
  • Not renewing 3

Plan to renew, by seniority

  • C-Suite 50% 10 answers
  • Director 82% 11 answers
  • Manager 100% 2 answers
  • Not specified 0% 1 answer
  • 8.5/10 Average score from customers who will renew
  • 7.4/10 Average score from undecided customers
  • 7/10 Average score from customers not renewing

Top alternatives

Most weighed by RxLogix customers

Report

Nov 2026 25 + 0

For people who use RxLogix

Do you use RxLogix at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 25 customers of RxLogix have already contributed

Takes a few minutes. Your identity stays anonymous.